SUCCESSFUL INTERLEUKIN-2 THERAPY OF ADVANCED CUTANEOUS T-CELL LYMPHOMA

被引：7

作者：

RYBOJAD, M

MAROLLEAU, JP

FLAGEUL, B

BACCARD, M

BRANDELY, M

MOREL, P

GISSELBRECHT, C

机构：

[1] ROUSSEL UCLAF,F-93230 ROMAINVILLE,FRANCE

[2] HOP ST LOUIS,DEPT HEMATOL,F-75010 PARIS,FRANCE

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1992年 / 127卷 / 01期

关键词：

D O I：

10.1111/j.1365-2133.1992.tb14832.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：63 / 64

页数：2

相关论文

共 4 条

[1] CUTANEOUS T-CELL LYMPHOMA WITH SUPPRESSOR CYTOTOXIC (CD8) PHENOTYPE - IDENTIFICATION OF RAPIDLY PROGRESSIVE AND CHRONIC SUBTYPES [J].

AGNARSSON, BA ;

VONDERHEID, EC ;

KADIN, ME .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (04) :569-577

[2] PHASE-II TRIAL OF OUTPATIENT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMA, CHRONIC LYMPHOCYTIC-LEUKEMIA, AND SELECTED SOLID TUMORS [J].

ALLISON, MAK ;

JONES, SE ;

MCGUFFEY, P .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :75-80

[3]

NAGATANI T, 1988, ACTA DERM-VENEREOL, V68, P504

[4] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

CHANG, AE ;

AVIS, FP ;

LEITMAN, S ;

LINEHAN, WM ;

ROBERTSON, CN ;

LEE, RE ;

RUBIN, JT ;

SEIPP, CA ;

SIMPSON, CG ;

WHITE, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897